#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Colorectal cancer Dementia Alzheimer's type Ovarian cancer Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Myasthenia gravis Dementia Alzheimer's type Intracranial calcification Palmoplantar pustulosis Oesophageal adenocarcinoma Amyotrophic lateral sclerosis gene carrier Palmar-plantar erythrodysaesthesia syndrome B-cell lymphoma recurrent SAPHO syndrome Duchenne muscular dystrophy gene carrier Retinal dystrophy Vulval cancer Fusarium infection Myotonia Malignant oligodendroglioma More trials…

    Learn about Rare Diseases

    Alveolar rhabdomyosarcoma – Trials in Disease Mucopolysaccharidosis III Thrombotic thrombocytopenic purpura – Treatment Fabry’s disease – Treatment Waldenstrom’s macroglobulinaemia – Life with Disease Atypical haemolytic uraemic syndrome Sjogren’s syndrome – Treatment Cystic fibrosis lung – Trials in Disease Systemic mastocytosis – Diagnostics Chondrosarcoma – Basic Information More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    PEGVISOMANT Cefalexin Monohydrate Ianalumab ZALFERMIN LUNRESERTIB Lidocaine Hydrochloride Glycopyrronium Bromide Efzofitimod Ganciclovir Sodium L-Arginine Hydrochloride IHMA-2121908-1 Ganaxolone Plasma Imiquimod Sym025 Aup1602-C Rifaximin Clopidogrel Luspatercept Rosuvastatin Calcium More therapies…

    Learn about Your Condition

    Systemic candida Neuroblastoma recurrent Pleural mesothelioma Tonsillitis Crigler-Najjar syndrome Systemic sclerosis pulmonary Chronic disease Neuromyopathy Latent tuberculosis Thalassaemia Radius fracture Bipolar disorder Adenomyosis Pyrexia Neuroendocrine tumour More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Autism spectrum disorder

  • Study on Improving Social Interaction in Children with Autism Using Oxytocin Nasal Spray and Therapy

    Recruiting

    3 1 1
    Investigated Diseases:
    • Autism spectrum disorder
    Investigated Drugs:
    • Oxytocin
    Belgium

  • Study on Oxytocin Treatment for Children with Autism and Intellectual Disability

    Recruiting

    3 1 1
    Investigated Diseases:
    • Autism spectrum disorder
    Investigated Drugs:
    • Oxytocin
    Belgium

  • Study on Arbaclofen for Improving Social Function in Children and Adolescents with Autism Spectrum Disorder

    Recruiting

    3 1 1
    Investigated Drugs:
    • Arbaclofen
    France Spain

  • Study on the Effects of Intranasal Oxytocin on Learning in Youth with Autism Spectrum Disorder

    Recruiting

    2 1 1
    Investigated Diseases:
    • Autism spectrum disorder
    Investigated Drugs:
    • Oxytocin Synthetic
    • Oxytocin
    • Sodium Chloride
    Norway

  • Studying the Safety of Aripiprazole and Risperidone in Children and Adolescents with Autism Spectrum Disorder

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Autism spectrum disorder
    Investigated Drugs:
    • Aripiprazole
    • Risperidone
    Germany The Netherlands

  • Long‑Term Safety and Tolerability of KarXT in Adolescents with Schizophrenia and of KarXT + KarX‑EC in Children and Adolescents with Autism‑Related Irritability

    Not yet recruiting

    3 1 1
    Investigated Diseases:
    • Autism spectrum disorder
    • Schizophrenia
    Investigated Drugs:
    • Trospium Chloride
    • Xanomeline Tartrate
    Romania
1 2 3
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!